相关实验视频

Updated: Jun 22, 2025

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells MBC-P and Biofilm Cells MBC-B
06:36

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells MBC-P and Biofilm Cells MBC-B

Published on: January 2, 2014

20.0K

在产生VIM的PBP-3定向治疗中,Pseudomonas aeruginosa产生了细菌转换器,在伪装中持续存在

Nicholas M Smith1, Katie Rose Boissonneault1, Patricia N Holden1

  • 1Division of Clinical and Translational Therapeutics, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.

International journal of antimicrobial agents
|June 30, 2024
PubMed
概括

产生金属β-乳糖酶 (MBL) 的Pseudomonas aeruginosa是一种公共卫生威胁,可以转化为持久形式. 基于阿兹特雷的疗法减少了细菌的数量,但在停止治疗后,P. aeruginosa迅速恢复到杆状.

关键词:
空洞纤维感染模型的空洞纤维感染模型金属β-乳酸酶的使用.坚持不,坚持不.药理动力学是什么 药理动力学药理动力学 药理动力学伪omonas空气菌 伪omonas空气菌维罗纳综合体金属β-乳糖酶

更多相关视频

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

33.0K
The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms05:57

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

13.4K

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
318